Skip to main content
S 2081 116th Congress Senate

Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019

Official title: A bill to amend title XVIII of the Social Security Act to require drug manufacturers to provide rebates for drugs furnished under Medicare part B for which the… Show full official titleShow less

Official title: A bill to amend title XVIII of the Social Security Act to require drug manufacturers to provide rebates for drugs furnished under Medicare part B for which the growth in average sales price has exceeded inflation, and for other purposes.

Introduced: July 10, 2019 Introduced by: Peters, Gary C. Democratic · Michigan See on congress.gov
Health Government information and archivesGovernment trust fundsHealth care costs and insuranceHome and outpatient care
More subjectsShow fewer subjects
Inflation and pricesManufacturingMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 10, 2019
Read twice and referred to the Committee on Finance.
Jul 10, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 10, 2019

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019

This bill requires manufacturers of covered drugs under Medicare medical services to issue rebates to the Centers for Medicare & Medicaid Services. Rebates are calculated based on the number of units sold and the amount by which the manufacturer price exceeds inflation. The bill's requirements do not apply to drugs that cost less than $100 annually per user in 2020 (and as adjusted for inflation annually thereafter) or to drugs on a specified drug shortage list.

The bill also eliminates cost-sharing for such drugs for beneficiaries whose out-of-pocket costs meet or exceed a specified threshold.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2081: Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-2081/
MLA
"S. 2081: Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2081/.
Bluebook (legal)
S. 2081, 116th Cong. (2026), https://openamerica.io/bill/116-S-2081/.
Markdown link
[S. 2081: Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019](https://openamerica.io/bill/116-S-2081/)
Report a problem